Expression of chemokines and their receptors, such as CXCL12/CXCR4 and CCL21/CCR7, in both primary and metastatic tumors suggest that chemokine receptor-bearing cells actively enter the circulation and home to metastatic sites [12]. The gene discussed is CXCR4; the disease is metastatic neoplasm.